The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Exelon's revenues will grow 114.9% and EPS will shrink -20.7%.
The average estimate for revenue is $9.13 billion. On the bottom line, the average EPS estimate is $0.65.
Last quarter, Exelon tallied revenue of $7.03 billion. GAAP reported sales were 25% higher than the prior-year quarter's $5.25 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.77. GAAP EPS of $0.35 for Q3 were 61% lower than the prior-year quarter's $0.90 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 26.1%, 660 basis points worse than the prior-year quarter. Operating margin was 14.0%, 850 basis points worse than the prior-year quarter. Net margin was 4.5%, 690 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $25.59 billion. The average EPS estimate is $2.86.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 1,917 members out of 1,974 rating the stock outperform, and 57 members rating it underperform. Among 480 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 465 give Exelon a green thumbs-up, and 15 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Exelon is hold, with an average price target of $38.75.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Exelon. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add Exelon to My Watchlist.